Authors
Loading...
Cellular experiments showed aurantiamide acetate reduces MAPK activation and cardiac enlargement in H9C2 cells, suggesting its potential in treating hypertensive cardiac hypertrophy.
Çeker et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: